Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid Tumors or Lymphomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00016172
What this trial is testing

ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Ended earlyNCT01296555
What this trial is testing

A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma (NHL) and in Combination With Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer

Who this might be right for
Solid CancersNon-Hodgkin's Lymphoma
Genentech, Inc. 674
Testing effectiveness (Phase 2)Active Not RecruitingNCT06303167
What this trial is testing

Testing AZD9291 as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH-Subprotocol E)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 19
Early research (Phase 1)Study completedNCT03809767
What this trial is testing

CS1003 in Subjects With Advanced Solid Tumors or Lymphomas

Who this might be right for
Solid TumorLymphoma
CStone Pharmaceuticals 107
Early research (Phase 1)Study completedNCT00725634
What this trial is testing

Dose-Escalation Study in Advanced Solid Tumors, Lymphomas or Multiple Myeloma

Who this might be right for
Malignant Solid TumorLymphomasMultiple Myeloma
AVEO Pharmaceuticals, Inc. 41
Early research (Phase 1)Study completedNCT00677105
What this trial is testing

A Safety and Dose-finding Study of JNJ-26481585 for Patients With Advanced Solid Malignancies and Lymphoma.

Who this might be right for
LymphomaNeoplasms
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 92
Early research (Phase 1)WithdrawnNCT01490047
What this trial is testing

Single Dose of Intravenous rhTNF-α and Liposomal Doxorubicin in Patients With Advanced Solid Tumors or Lymphomas

Who this might be right for
Solid TumorsLymphomas
Ludwig Institute for Cancer Research
Early research (Phase 1)Active Not RecruitingNCT05878691
What this trial is testing

GRC 54276 in Participants With Advanced Solid Tumors and Lymphomas.

Who this might be right for
Advanced Solid TumorLymphoma
Glenmark Specialty S.A. 320
Early research (Phase 1)UnknownNCT03775525
What this trial is testing

Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer

Who this might be right for
Advanced CancerGastric CancerBreast Cancer+14 more
Genzada Pharmaceuticals USA, Inc. 127
Early research (Phase 1)Study completedNCT00443976
What this trial is testing

Aurora Kinase Inhibitor AT9283 in Treating Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkins LymphomaUnspecified Adult Solid Tumor, Protocol Specific
NCIC Clinical Trials Group 35
Early research (Phase 1)WithdrawnNCT03359733
What this trial is testing

Evaluate the Effect of Food on the Pharmacokinetics (PK) of TAK-659 in Participants With Advanced Solid Tumor

Who this might be right for
Lymphoma, MalignantAdvanced Solid Neoplasms
Calithera Biosciences, Inc
Early research (Phase 1)Study completedNCT00935844
What this trial is testing

Study of TAK-901 in Adults With Advanced Solid Tumors or Lymphoma

Who this might be right for
Advanced Solid TumorsLymphoma
Millennium Pharmaceuticals, Inc. 20
Early research (Phase 1)Study completedNCT04970992
What this trial is testing

A Pharmacokinetic and Pharmacodynamic Study of DZ-002 in Patients With Advanced Solid Malignancies or Lymphoma

Who this might be right for
Solid TumorLymphoma
Da Zen Theranostics Inc 14
Early research (Phase 1)Study completedNCT00316511
What this trial is testing

Study of L-NDDP (Aroplatin) in Patients With Advanced Solid Malignancies or B-Cell Lymphoma

Who this might be right for
MalignanciesB-Cell Lymphoma
Agenus Inc. 21
Early research (Phase 1)Study completedNCT00955786
What this trial is testing

Dose-escalation Study of CX-3543 in Patients With Advanced Solid Tumors or Lymphomas

Who this might be right for
Advanced Solid TumorsLymphoma
Cylene Pharmaceuticals 48
Testing effectiveness (Phase 2)UnknownNCT04407741
What this trial is testing

Phase Ⅰ/Ⅱ Study of SHR2554 in Combination With SHR1701 in Patients With Advanced Solid Tumors and B-cell Lymphomas

Who this might be right for
Solid TumorLymphoma
Chinese PLA General Hospital 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439266
What this trial is testing

Testing Crizotinib as a Potential Targeted Treatment in Cancers With ALK Genetic Changes (MATCH-Subprotocol F)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 5
Early research (Phase 1)Study completedNCT02518958
What this trial is testing

A Phase I, Open-Label, Multiple Ascending Dose Study of RRx-001 and Nivolumab

Who this might be right for
Malignant Solid TumorLymphoma
EpicentRx, Inc. 12
Early research (Phase 1)Ended earlyNCT01908413
What this trial is testing

Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-427 When Given to Patients With Advanced and Refractory Solid Tumors or Lymphoma

Who this might be right for
Lymphoma
Curis, Inc. 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT03678883
What this trial is testing

9-ING-41 in Patients With Advanced Cancers

Who this might be right for
CancerPancreatic CancerSarcoma+22 more
Actuate Therapeutics Inc. 350
Next Page